NSEGeneral Updates4d ago · 26 Aug 2026, 04:27 pm

General Updates

Krishna Institute of Medical Sciences Limited · KIMS

✦ AI Summary▼ NegativeRegulatory

Krishna Institute of Medical Sciences Limited has clarified that a news report about acquiring a stake in Renova Hospitals for $52 million is false and baseless.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Krishna Institute of Medical Sciences Limited has informed the Exchange about Clarification regarding article appearing in Dealstreetasia.com dated 25th August 2026 titled ChrysCapital- backed KIMS in talks to acquire stake in Renova Hospitals for $52 Million

Attachments (1)

📄

KIMS_26082026162658_Mediadisclosures.pdf

pdf

Download →
View document text
26th August, 2026 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, Dalal Street, 5th Floor Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS ISIN: INE967H01025 Dear Sir/Madam, Sub: Clarification regarding article appearing in Dealstreetasia.com dated 25th August 2026 titled “ChrysCapital- backed KIMS in talks to acquire stake in Renova Hospitals for $52 Million” This is with reference to the news item/article titled “ChrysCapital- backed KIMS in talks to acquire stake in Renova Hospitals for $52 Million” published in dealstreetasia.com. We would like to clarify that the contents of the said news report/article are completely false, baseless, and factually incorrect. As on date, the Company has neither entered into any such agreement or memorandum of understanding (“MOU”), nor has it engaged in any discussions as alleged in the said report. The Company therefore requests that the aforesaid clarification be taken on record and the baseless speculation and rumours contained in the report be disregarded. The Company further confirms that it continues to comply with all applicable disclosure requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company will continue to make appropriate disclosures to the Stock Exchanges regarding any material development, event or information, as and when required under the applicable laws and regulations. Kindly take the above on your record. Thanking You, Yours truly For Krishna Institute of Medical Sciences Limited Dr. Nagajayanthi J. R. Company Secretary and Compliance Officer